The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 1,201–1,400 of 3,517
Fujioka, T., Fujioka, A., & Duman, R. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1065.03.2004 · Cited by 191
Lewy, A. J., Sack, R. L., Singer, C. M., Whate, D. M., & Hoban, T. M. (1988) · Journal of Biological Rhythms · doi:10.1177/074873048800300203 · Cited by 190
Janicak, P. G., Dowd, S. M., Martis, B., Alam, D., Beedle, D., Krasuski, J., Strong, M. J., Sharma, R., Rosen, C., & Viana, M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01354-3 · Cited by 190
Yau, J. L. W., Noble, J., Kenyon, C. J., Hibberd, C., Kotelevtsev, Y., Mullins, J. J., & Seckl, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071562698 · Cited by 190
Russo-Neustadt, A. A., Alejandre, H., Garcia, C., Ivy, A. S., & Chen, M. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300514 · Cited by 190
G‐protein coupled receptor kinases as modulators of G‐protein signalling
Bünemann, M., & Hosey, M. M. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0005z.x · Cited by 190
Pharmacology of antidepressants: focus on nefazodone.
DeVane, C. L., Grothe, D. R., & Smith, S. L. (2002) · PubMed · Cited by 189
DeBattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., Fieve, R. R., & Modafinil in Depression Study Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0911 · Cited by 189
Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
Moghaddam, B. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1792-z · Cited by 189
Fewer Genes, More Noncoding RNA
Claverie, J.-M. (2005) · Science · doi:10.1126/science.1116800 · Cited by 189
Nitric oxide and neurological disorders
DUNCAN, A., & HEALES, S. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.09.004 · Cited by 189
Nelson, J. C., Mazure, C. M., Jatlow, P. I., Bowers, M. B., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.007 · Cited by 189
Small-Dose Ketamine Improves the Postoperative State of Depressed Patients
Kudoh, A., Takahira, Y., Katagai, H., & Takazawa, T. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200207000-00020 · Cited by 189
Is impaired neurogenesis relevant to the affective symptoms of depression?
Sapolsky, R. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.012 · Cited by 188
Potential of Substance P Antagonists as Antiemetics
Diemunsch, P., & Gr??lot, L. (2000) · Drugs · doi:10.2165/00003495-200060030-00002 · Cited by 188
Molecular and Cellular Actions of Chronic Electroconvulsive Seizures
Duman, R. S., & Vaidya, V. A. (1998) · Journal of Ect · doi:10.1097/00124509-199809000-00004 · Cited by 188
The pharmacology of weight gain with antipsychotics.
Casey, D. E., & Zorn, S. H. (2001) · PubMed · Cited by 187
Berman, J. R., & Goldstein, I. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70148-8 · Cited by 187
Paracrine neurotransmission in the CNS: involvement of 5-HT
Bunin, M. A., & Wightman, R. M. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01410-1 · Cited by 187
Portoghese, P. S. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010158+ · Cited by 187
Corelease of Dopamine and Serotonin from Striatal Dopamine Terminals
Zhou, F.-M., Liang, Y., Salas, R., Zhang, L., De Biasi, M., & Dani, J. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.010 · Cited by 187
Umbricht, D., Vollenweider, F. X., Schmid, L., Grübel, C., Skrabo, A., Huber, T., & Koller, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300005 · Cited by 187
Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways
Taylor, C., Fricker, A. D., Devi, L. A., & Gomes, I. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.007 · Cited by 186
Antidepressants and Suicide Risk in the United States, 1985–1999
Grunebaum, M. F., Ellis, S. P., Li, S., Oquendo, M. A., & Mann, J. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1103 · Cited by 186
Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomised comparison
Poirier, M.-F., & Boyer, P. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.12 · Cited by 185
Feiger, A. D., Kiev, A., Shrivastava, R. K., Wisselink, P., & Wilcox, C. S. (1996) · PubMed · Cited by 185
Arai, R., Karasawa, N., Geffard, M., & Nagatsu, I. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11817-g · Cited by 185
Neuroanatomical localisation of Substance P in the CNS and sensory neurons
Ribeiro-da-Silva, A., & Hökfelt, T. (2000) · Neuropeptides · doi:10.1054/npep.2000.0834 · Cited by 185
Cryan, J. F., Page, M. E., & Lucki, I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01628-4 · Cited by 185
Li, X., Nahas, Z., Kozel, F. A., Anderson, B., Bohning, D. E., & George, M. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.017 · Cited by 185
Padberg, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00338-x · Cited by 185
Franowicz, J. S., Kessler, L. E., Borja, C. M. D., Kobilka, B. K., Limbird, L. E., & Arnsten, A. F. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08771.2002 · Cited by 185
Nongenomic membrane actions of glucocorticoids in vertebrates
Borski, R. J. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00325-8 · Cited by 184
Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Jahn, H., Schick, M., Kiefer, F., Kellner, M., Yassouridis, A., & Wiedemann, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1235 · Cited by 184
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression
Brunello, N. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00057-3 · Cited by 184
The distribution of nitric oxide synthase immunoreactivity in the human brain
Egberongbe, Y. I., Gentleman, S. M., Falkai, P., Bogerts, B., Polak, J. M., & Roberts, G. W. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90177-5 · Cited by 184
Friedman, J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1794-x · Cited by 184
Cooper, B. R., Wang, C. M., Cox, R. F., Norton, R., Shea, V., & Ferris, R. M. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.43 · Cited by 184
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
Goodnick, P. J., & Goldstein, B. J. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003021 · Cited by 183
Stahl, S., & Grady, M. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456070 · Cited by 183
Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression
Meltzer, C. C., Price, J. C., Mathis, C. A., Butters, M. A., Ziolko, S. K., Moses-Kolko, E., Mazumdar, S., Mulsant, B. H., Houck, P. R., Lopresti, B. J., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300556 · Cited by 183
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites
Raasch, W., Schäfer, U., Chun, J., & Dominiak, P. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704153 · Cited by 183
Interactions between NPY and CRF in the amygdala to regulate emotionality
Sajdyk, T. J., Shekhar, A., & Gehlert, D. R. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.006 · Cited by 183
Thomas, D., & Hagan, J. (2004) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007043482633 · Cited by 183
Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles
Grabovsky, Y., & Tallarida, R. J. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067264 · Cited by 183
Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes
Segars, J. H., & Driggers, P. H. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00633-1 · Cited by 182
Ravard, S., & Dourish, C. T. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90004-r · Cited by 182
Barbui, C., & Hotopf, M. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.129 · Cited by 182
Rachman, I. M., Unnerstall, J. R., Pfaff, D. W., & Cohen, R. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13941 · Cited by 182
Kole, M. H. P., Swan, L., & Fuchs, E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02136.x · Cited by 181
Dynamic regulation of the dopamine transporter
Mortensen, O. V., & Amara, S. G. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.066 · Cited by 181
Yang, C.-H., Huang, C.-C., & Hsu, K.-S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0406-05.2005 · Cited by 181
Prisco, S., & Esposito, E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16684.x · Cited by 181
Groves, D. A., Bowman, E. M., & Brown, V. J. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.055 · Cited by 181
Burden, D. A., & Philips, S. R. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb11267.x · Cited by 181
Cortisol Activity and Cognitive Changes in Psychotic Major Depression
Belanoff, J. K., Kalehzan, M., Sund, B., Fleming Ficek, S. K., & Schatzberg, A. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1612 · Cited by 181
Urani, A., Roman, F. J., Phan, V. L., Su, T., & Maurice, T. (2001) · PubMed · Cited by 181
A duplication growth model of gene expression networks
Bhan, A., Galas, D. J., & Dewey, T. G. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1486 · Cited by 181
Neuronal Regulation: A Mechanism for Synaptic Pruning During Brain Maturation
Chechik, G., Meilijson, I., & Ruppin, E. (1999) · Neural Computation · doi:10.1162/089976699300016089 · Cited by 181
Neuroendocrine basis of social recognition
Winslow, J. T., & Insel, T. R. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.03.009 · Cited by 180
Specific characteristics of the pain/depression association in the general population.
Ohayon, M. M. (2004) · PubMed · Cited by 180
Herrick‐Davis, K., Grinde, E., & Niswender, C. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.731711.x · Cited by 180
WERRY, T. D., WILKINSON, G. F., & WILLARS, G. B. (2003) · Biochemical Journal · doi:10.1042/bj20030312 · Cited by 180
Reduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors
Tschenett, A., Singewald, N., Carli, M., Balducci, C., Salchner, P., Vezzani, A., Herzog, H., & Sperk, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02725.x · Cited by 180
A-to-I RNA Editing: Recent News and Residual Mysteries
Maas, S., Rich, A., & Nishikura, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200025200 · Cited by 180
Separate systems for serotonin and leptin in appetite control
Halford, J. C. G., & Blundell, J. E. (2000) · Annals of Medicine · doi:10.3109/07853890008998829 · Cited by 180
Saitoh, A., Kimura, Y., Suzuki, T., Kawai, K., Nagase, H., & Kamei, J. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj04014x · Cited by 180
Estrogen-mediated effects on depression and memory formation in females
Shors, T. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00428-7 · Cited by 180
Levodopa therapy: Consequences of the nonphysiologic replacement of dopamine
Chase, T. N. (1998) · Neurology · doi:10.1212/wnl.50.5_suppl_5.s17 · Cited by 180
Depression, sleep physiology, and antidepressant drugs
Winokur, A., Gary, K. A., Rodner, S., Rae-Red, C., Fernando, A. T., & Szuba, M. P. (2001) · Depression and Anxiety · doi:10.1002/da.1043 · Cited by 179
Antidepressant effects of ERβ-selective estrogen receptor modulators in the forced swim test
Walf, A. A., Rhodes, M. E., & Frye, C. A. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.023 · Cited by 179
Open-Channel Blockers at the Human α4β2 Neuronal Nicotinic Acetylcholine Receptor
Buisson, B., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.555 · Cited by 179
Frontostriatal and Limbic Dysfunction in Late-Life Depression
Alexopoulos, G. S. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200211000-00007 · Cited by 179
Current pharmacological treatments for nicotine dependence
George, T. P., & O'Malley, S. S. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.11.003 · Cited by 179
Blier, P., Chaput, Y., & de Montigny, C. (1988) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00168834 · Cited by 179
Newman-Tancredi, A., Cussac, D., Audinot, V., Nicolas, J.-P., De Ceuninck, F., Boutin, J.-A., & Millan, M. J. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039875 · Cited by 179
Self-citationXia, Z., Gray, J. A., Compton-Toth, B. A., & Roth, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301905200 · Cited by 179
Bielski, R. J., Ventura, D., & Chang, C.-C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0906 · Cited by 178
Heal, D. J., Aspley, S., Prow, M. R., Jackson, H. C., Martin, K. F., & Cheetham, S. (1998) · PubMed · Cited by 178
The GABA B receptor interacts directly with the related transcription factors CREB2 and ATFx
White, J. H., McIllhinney, R. A. J., Wise, A., Ciruela, F., Chan, W.-Y., Emson, P. C., Billinton, A., & Marshall, F. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240452197 · Cited by 178
Vagus nerve stimulation therapy summary: Five years after FDA approval
Schachter, S. C. (2002) · Neurology · doi:10.1212/wnl.59.6_suppl_4.s15 · Cited by 178
Body weight is regulated by the brain: a link between feeding and emotion
Kishi, T., & Elmquist, J. K. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001638 · Cited by 178
Baclofen Inhibits Heroin Self-Administration Behavior and Mesolimbic Dopamine Release
Xi, Z.-X., & Stein, E. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35044-x · Cited by 177
Heilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjögren, M., Åsberg, M., Ekman, R., Wahlestedt, C., & Ågren, H. (2004) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00101-8 · Cited by 177
Boutrel, B., Franc, B., Hen, R., Hamon, M., & Adrien, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03204.1999 · Cited by 177
Sexual Behavior and Sex-Associated Environmental Cues Activate the Mesolimbic System in Male Rats
Balfour, M. E., Yu, L., & Coolen, L. M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300350 · Cited by 177
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment
Perlis, R. H., Mischoulon, D., Smoller, J. W., Wan, Y.-J. Y., Lamon-Fava, S., Lin, K.-M., Rosenbaum, J. F., & Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00424-4 · Cited by 177
Jacobsen, J. P. R., & Mørk, A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.065 · Cited by 177
Buccafusco, J. J., Letchworth, S. R., Bencherif, M., & Lippiello, P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.05.007 · Cited by 177
Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue?
Scharfman, H. E., & MacLusky, N. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2004.12.005 · Cited by 177
Smits, K. M., Smits, L. J. M., Schouten, J. S. A. G., Stelma, F. F., Nelemans, P., & Prins, M. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001488 · Cited by 177
The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior
Heinrichs, S. C., & Richard, D. (1999) · Neuropeptides · doi:10.1054/npep.1999.0047 · Cited by 177
Future therapeutic targets in mood disorders: the glucocorticoid receptor
McQuade, R., & Young, A. H. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.5.390 · Cited by 177
Blockage of 5HT2Cserotonin receptors by fluoxetine (Prozac)
Ni, Y. G., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2036 · Cited by 177
Zolpidem for Persistent Insomnia in SSRI-Treated Depressed Patients
Asnis, G. M., Chakraburtty, A., DuBoff, E. A., Krystal, A., Londborg, P. D., Rosenberg, R., Roth-Schechter, B., Scharf, M. B., & Walsh, J. K. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1005 · Cited by 176
Neuropathic pain : pathophysiology and treatment
Hansson, P. T. (2001) · Medical Entomology and Zoology · Cited by 176
Hammack, S. E., Schmid, M. J., LoPresti, M. L., Der-Avakian, A., Pellymounter, M. A., Foster, A. C., Watkins, L. R., & Maier, S. F. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-01019.2003 · Cited by 176
Glass, J. D., Grossman, G. H., Farnbauch, L., & DiNardo, L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07451.2003 · Cited by 176
Co-evolutionary Analysis Reveals Insights into Protein–Protein Interactions
Goh, C.-S., & Cohen, F. E. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01038-0 · Cited by 176
Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89020-3 · Cited by 176
Clinical Aspects of the MDR1 (ABCB1) Gene Polymorphism
Eichelbaum, M., Fromm, M. F., & Schwab, M. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00017 · Cited by 176
Nitric oxide inhibits [3H]dopamine uptake
Pogun, S., Baumann, M. H., & Kuhar, M. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91818-x · Cited by 176
The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals
Argiolas, A., & Melis, M. R. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.08.019 · Cited by 176
Molecular and cellular actions of chronic electroconvulsive seizures.
Duman, R. S., & Vaidya, V. A. (1998) · PubMed · Cited by 176
Bauer, M., Bschor, T., Kunz, D., Berghöfer, A., Ströhle, A., & Müller-Oerlinghausen, B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1429 · Cited by 176
The effects of tryptophan depletion on mood and psychiatric symptoms
Van der Does, A. J. W. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00209-3 · Cited by 176
Lomarev, M., Denslow, S., Nahas, Z., Chae, J.-H., George, M. S., & Bohning, D. E. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00013-4 · Cited by 175
Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?
Pacher, P., & Kecskemeti, V. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455594 · Cited by 175
The melatonin receptor in the human brain: cloning experiments and distribution studies
Mazzucchelli, C., Pannacci, M., Nonno, R., Lucini, V., Fraschini, F., & Michaylov Stankov, B. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00017-4 · Cited by 175
Jedema, H. P., & Grace, A. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2830-04.2004 · Cited by 175
Xanomeline and the Antipsychotic Potential of Muscarinic Receptor Subtype Selective Agonists
Mirza, N. R., Peters, D., & Sparks, R. G. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00247.x · Cited by 175
Yau, J. L. W., Olsson, T., Morris, R. G. M., Meaney, M. J., & Seckl, J. R. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00612-9 · Cited by 175
Bao, A.-M., Hestiantoro, A., Van Someren, E. J. W., Swaab, D. F., & Zhou, J.-N. (2005) · Brain · doi:10.1093/brain/awh448 · Cited by 175
Puskás, L. G., Kitajka, K., Nyakas, C., Barcelo-Coblijn, G., & Farkas, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337683100 · Cited by 175
Cytokines and depression: fortuitous or causative association?
Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000572 · Cited by 174
Geisser, M. E., Roth, R. S., Theisen, M. E., Robinson, M. E., & Riley, J. L. (2000) · The Clinical Journal of Pain · doi:10.1097/00002508-200006000-00004 · Cited by 174
Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats
Yildiz, F., Erden, B. F., Ulak, G., Utkan, T., & Gacar, N. (2000) · Psychopharmacology · doi:10.1007/s002139900316 · Cited by 174
How does pindolol improve antidepressant action?
Artigas, F., Celada, P., Laruelle, M., & Adell, A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01682-5 · Cited by 174
The Dexamethasone Suppression Test in Patients With Mood Disorders
Rush, A. J., Giles, D. E., Schlesser, M. A., Orsulak, P. J., Parker, C. R., Weissenburger, J. E., Crowley, G. T., Khatami, M., & Vasavada, N. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1006 · Cited by 174
Egeland, J., Rund, B. R., Sundet, K. S., Landrø, N. I., Asbjørnsen, A. E., Lund, A., Roness, A., Stordal, K. I., & Hugdahl, K. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00146.x · Cited by 174
High-throughput drug discovery: What can we expect from HTS?
Gribbon, P., & Andreas, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03275-1 · Cited by 174
Black, M. D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2065-6 · Cited by 174
Contributions of 5-HT2C receptors to multiple actions of central serotonin systems
Giorgetti, M., & Tecott, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.036 · Cited by 173
Cholinergic mechanisms in depression
Dilsaver, S. C. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90016-0 · Cited by 173
Synaptic multiprotein complexes associated with 5-HT2C receptors: a proteomic approach
Becamel, C. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2332 · Cited by 173
ROBINSON, D. S., RICKELS, K., FEIGHNER, J., FABRE, L. F., GAMMANS, R. E., SHROTRIYA, R. C., ALMS, D. R., ANDARY, J. J., & MESSINA, M. E. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199006001-00013 · Cited by 173
Mood disorders and medical illness: a major public health problem
Evans, D. L., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00639-5 · Cited by 173
Baumann, P., Nil, R., Souche, A., Montaldi, S., Baettig, D., Lambert, S., Uehlinger, C., Kasas, A., Amey, M., & Jonzier-Perey, M. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199608000-00006 · Cited by 173
Looking beyond the details: a rise in system-oriented approaches in genetics and molecular biology
Kitano, H. (2002) · Current Genetics · doi:10.1007/s00294-002-0285-z · Cited by 173
Shakesby, A. C., Anwyl, R., & Rowan, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03638.2002 · Cited by 173
Karpa, K. D., Lin, R., Kabbani, N., & Levenson, R. G. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.677 · Cited by 173
Fisher, A., Pittel, Z., Haring, R., Bar-Ner, N., Kliger-Spatz, M., Natan, N., Egozi, I., Sonego, H., Marcovitch, I., & Brandeis, R. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:349 · Cited by 173
Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression
Zhou, J.-N., Riemersma, R. F., Unmehopa, U. A., Hoogendijk, W. J. G., van Heerikhuize, J. J., Hofman, M. A., & Swaab, D. F. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.7.655 · Cited by 172
Dopamine Increases Excitability of Pyramidal Neurons in Primate Prefrontal Cortex
Henze, D. A., González-Burgos, G. R., Urban, N. N., Lewis, D. A., & Barrionuevo, G. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.84.6.2799 · Cited by 172
All-night spectral analysis of the sleep EEG in untreated depressives and normal controls
Borbély, A. A., Tobler, I., Loepfe, M., Kupfer, D. J., Ulrich, R. F., Grochocinski, V., Doman, J., & Matthews, G. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90135-5 · Cited by 172
Pain Genes?: Natural Variation and Transgenic Mutants
Mogil, J. S., Yu, L., & Basbaum, A. I. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.777 · Cited by 172
Goodyer, I. M., Herbert, J., Tamplin, A., & Altham, P. M. E. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.2.142 · Cited by 172
Goldstein, B. J., & Goodnick, P. J. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003041 · Cited by 171
Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney
Wu, X., Huang, W., Ganapathy, M. E., Wang, H., Kekuda, R., Conway, S. J., Leibach, F. H., & Ganapathy, V. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f449 · Cited by 171
Rajan, V, Edwards, C., & Seckl, Jr. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00065.1996 · Cited by 171
Stress and hippocampal abnormalities in psychiatric disorders
SALA, M. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.12.005 · Cited by 171
Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders?
Griebel, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00041-2 · Cited by 171
Role of nitric oxide in the regulation of monoaminergic neurotransmission
Kiss, J. P. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00282-3 · Cited by 171
Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group
Nocjar, C., Roth, B. L., & Pehek, E. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00593-0 · Cited by 171
Gobert, A., & Millan, M. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00188-9 · Cited by 171
Self-citationVenlafaxine and paroxetine in treatment-resistant depression
Gregson, J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.6.591a · Cited by 171
Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.
Guelfi, J., White, C. M., Hackett, D., Guichoux, J. Y., & Magni, G. (1995) · PubMed · Cited by 170
Different properties of the central and peripheral forms of human tryptophan hydroxylase
McKinney, J., Knappskog, P. M., & Haavik, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02850.x · Cited by 170
Irritable Bowel Syndrome: New Agents Targeting Serotonin Receptor Subtypes
Ponti, F. D., & Tonini, M. (2001) · Drugs · doi:10.2165/00003495-200161030-00001 · Cited by 170
Neuropsychological deficits among patients with late-onset minor and major depression
ELDERKINTHOMPSON, V, KUMAR, A., BILKER, W., DUNKIN, J., MINTZ, J., MOBERG, P., MESHOLAM, R., & GUR, R. (2003) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(03)00022-2 · Cited by 170
Millan, M. J., Gobert, A., Rivet, J. ‐., Adhumeau‐Auclair, A., Cussac, D., Newman‐Tancredi, A., Dekeyne, A., Nicolas, J. ‐., & Lejeune, F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00982.x · Cited by 170
Self-citationDopaminergic mechanism of antidepressant action in depressed patients
Willner, P., Hale, A. S., & Argyropoulos, S. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.010 · Cited by 169
Rogóż, Z., Skuza, G., Maj, J., & Danysz, W. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00055-2 · Cited by 169
Hoefgen, B., Schulze, T. G., Ohlraun, S., von Widdern, O., Höfels, S., Groß, M., Heidmann, V., Kovalenko, S., Eckermann, A., Kölsch, H., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.027 · Cited by 169
Fiorino, D. F., & Phillips, A. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00456.1999 · Cited by 169
Depressive Symptoms in Schizophrenia
Zisook, S., McAdams, L. A., Kuck, J., Harris, M. J., Bailey, A., Patterson, T. L., Judd, L. L., & Jeste, D. V. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1736 · Cited by 169
Gorman, J. M., Korotzer, A., & Su, G. (2002) · CNS Spectrums · doi:10.1017/s1092852900028595 · Cited by 169
Bamigbade, T. A., Davidson, C., Langford, R. M., & Stamford, J. A. (1997) · British Journal of Anaesthesia · doi:10.1093/bja/79.3.352 · Cited by 169
Review of bupropion for smoking cessation
RICHMOND, R., & ZWAR, N. (2003) · Drug and Alcohol Review · doi:10.1080/09595230100100642 · Cited by 169
Neuropeptide Y (NPY) and depression: From animal studies to the human condition
Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02159-8 · Cited by 168
Efficacy of SSRIs and Newer Antidepressants in Severe Depression: Comparison With TCAs
Hirschfeld, R. M. A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0511 · Cited by 168
Genome-based pharmacogenetics and the pharmaceutical industry
Roses, A. D. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd840 · Cited by 168
Keck, M. E., Welt, T., Müller, M. B., Uhr, M., Ohl, F., Wigger, A., Toschi, N., Holsboer, F., & Landgraf, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300040 · Cited by 168
Stress-induced activation of nitric oxide-producing neurons in the rat brain
Krukoff, T. L., & Khalili, P. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970127)377:4<509::aid-cne3>3.0.co;2-6 · Cited by 168
Zhu, C.-B., Hewlett, W. A., Feoktistov, I., Biaggioni, I., & Blakely, R. D. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1462 · Cited by 168
Santos, M. D., Alkondon, M., Pereira Edna, F. R., Aracava, Y., Eisenberg, H. M., Maelicke, A., & Albuquerque, E. X. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12219-5 · Cited by 168
Leproult, R., Van Onderbergen, A., L’Hermite‐Balériaux, M., Van Cauter, E., & Copinschi, G. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02341.x · Cited by 167
Xu, H., Steven Richardson, J., & Li, X.-M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300009 · Cited by 167
Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo
Wegener, G., Volke, V., & Rosenberg, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703349 · Cited by 167
Depression: a major, unrecognized risk factor for osteoporosis?
Cizza, G., Ravn, P., Chrousos, G. P., & Gold, P. W. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00407-6 · Cited by 167
Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain
Caberlotto, L., Hurd, Y. L., Murdock, P. R., Wahlin, J.-P., Melotto, S., Corsi, M., & Carletti, R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02600.x · Cited by 167
De Vry, J., & Schreiber, R. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00083-4 · Cited by 167
Keck, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00351-7 · Cited by 167
Circadian rhythms and the pharmacology of affective illness
Duncan, W. C. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00092-7 · Cited by 167
Van Kampen, J. M., Hagg, T., & Robertson, H. A. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03342.x · Cited by 167
Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders
Sanacora, G., Rothman, D. L., Mason, G. F., & Krystal, J. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.018 · Cited by 167
Krauthammer, M., Kaufmann, C. A., Gilliam, T. C., & Rzhetsky, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404315101 · Cited by 167
Calogero, A. E., Gallucci, W. T., Chrousos, G. P., & Gold, P. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)90523-9 · Cited by 166
Neuropeptides and sexual behaviour
Argiolas, A. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00068-8 · Cited by 166
Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition
Youdim, M. B. H., Bar Am, O., Yogev‐Falach, M., Weinreb, O., Maruyama, W., Naoi, M., & Amit, T. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20350 · Cited by 166
Sprouse, J. S., Reynolds, L. S., Li, X., Braselton, J. P., & Schmidt, A. W. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.007 · Cited by 166
Wennström, M., Hellsten, J., Ekdahl, C. T., & Tingström, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00693-0 · Cited by 166
Boutrel, B., Monaca, C., Hen, R., Hamon, M., & Adrien, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04686.2002 · Cited by 166
Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus
Mullins, U. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00041-x · Cited by 166
Diverse functions of neuropeptide Y revealed using genetically modified animals
Thorsell, A., & Heilig, M. A. (2002) · Neuropeptides · doi:10.1054/npep.2002.0897 · Cited by 166
Benca, R. M., Okawa, M., Uchiyama, M., Ozaki, S., Nakajima, T., Shibui, K., & Obermeyer, W. H. (1997) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(97)90005-8 · Cited by 165
Barbosa, L., Berk, M., & Vorster, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0407 · Cited by 165
Winokur, A., DeMartinis, N. A., McNally, D. P., Gary, E. M., Cormier, J. L., & Gary, K. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1013 · Cited by 165
Antiglucocorticoid treatment of depression: double-blind ketoconazole
Wolkowitz, O. M., Reus, V. I., Chan, T., Manfredi, F., Raum, W., Johnson, R., & Canick, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00267-4 · Cited by 165
PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers
Manji, H. K., & Chen, G. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001018 · Cited by 165
The connectivity of the brain: multi-level quantitative analysis
Murre, J. M. J., & Sturdy, D. P. F. (1995) · Biological Cybernetics · doi:10.1007/bf00199545 · Cited by 165
Varty, G. B., Grilli, M., Forlani, A., Fredduzzi, S., Grzelak, M. E., Guthrie, D. H., Hodgson, R. A., Lu, S. X., Nicolussi, E., Pond, A. J., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2143-4 · Cited by 165
Gagné, G. G., Furman, M. J., Carpenter, L. L., & Price, L. H. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1960 · Cited by 165
Psychotherapy alone and combined with pharmacotherapy in the treatment of depression
de Jonghe, F. E. R. E. R., Hendricksen, M., van Aalst, G., Kool, S., Peen, V., Van, R., van den Eijnden, E., & Dekker, J. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.185.1.37 · Cited by 165
Sung, U., Apparsundaram, S., Galli, A., Kahlig, K. M., Savchenko, V. L., Schroeter, S., Quick, M. W., & Blakely, R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01697.2003 · Cited by 165
Genetic basis of anxiety-like behaviour: a critical review
Clément, Y., Calatayud, F., & Belzung, C. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00637-2 · Cited by 164
Harkin, A., Connor, T. J., Burns, M. P., & Kelly, J. P. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.010 · Cited by 164
Identification of the phenotype in psychiatric genetics
Tsuang, M. T., Faraone, S. V., & Lyons, M. J. (1993) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190719 · Cited by 164
VanderHorst, V., Gustafsson, J.-Α., & Ulfhake, B. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20569 · Cited by 164
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.